• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 417644 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1419259263 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1419259263 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Traders Get Bullish on Shares of Pacific Biosciences of California , Shares Up 8.3% (PACB)

Published on Tue, 01/08/2013 - 13:22
By Peter Chu

Pacific Biosciences of California (NASDAQ:PACB) is one of today's best performing low-priced stocks, up 8.3% to $1.95 on 1.3x average daily volume. Thus far today, Pacific Biosciences of California has traded 432,000 shares, vs. average volume of 332,000 shares per day. The stock has outperformed the Dow (8.3% to the Dow's -0.6%) and outperformed the S&P 500 (8.3% to the S&P's -0.6%) during today's trading.

Pacific Biosciences of California (NASDAQ:PACB) has potential upside of 8.5% based on a current price of $1.95 and analysts' consensus price target of $2.12. The stock should hit resistance at its 200-day moving average (MA) of $2.03, as well as support at its 50-day MA of $1.49.

In the past 52 weeks, shares of Pacific Biosciences of California have traded between a low of $1.06 and a high of $5.27 and are now at $1.95, which is 84% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 1.3% while the 50-day MA has advanced 2.5%.

Pacific Biosciences of California Inc. has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. The Company's system enables real-time analysis of biomolecules with single molecule resolution.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Willis Group In Retrospect: Shares Up 4....

UBS upgraded Willis Group (NYSE:WSH) from Neutral to Buy a week ago. The shares closed ...

Old Dominion Freight Line has Relatively...

Analysis was conducted on the Trucking industry to measure relative performance to find ...

Reynolds American had the Lowest Relativ...

Analysis was conducted on the Tobacco industry to measure relative performance to find ...

Short-term Underperformance Detected in ...

Below are five companies in the Thrifts & Mortgage Finance industry that underperformed ...

Short-term Underperformance Detected in ...

Below are five companies in the Specialty Stores industry that underperformed yesterday ...

Ferro had the Lowest Relative Performanc...

Analysis was conducted on the Specialty Chemicals industry to measure relative performa ...

Bottom 5 Companies in the Specialized RE...

Analysis was conducted on the Specialized REITs industry to measure relative performanc ...

Bottom 5 Companies in the Specialized Fi...

Below are five companies in the Specialized Finance industry that underperformed yester ...